Related references
Note: Only part of the references are listed.The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking
Leila Belle et al.
SCIENCE SIGNALING (2015)
The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking
Leila Belle et al.
SCIENCE SIGNALING (2015)
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin
Kristina Althoff et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Avnish Kapoor et al.
CELL (2014)
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Diane D. Shao et al.
CELL (2014)
Differences in DNA Methylation Signatures Reveal Multiple Pathways of Progression From Adenoma to Colorectal Cancer
Yanxin Luo et al.
GASTROENTEROLOGY (2014)
Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma
Jessica Theissen et al.
GENES CHROMOSOMES & CANCER (2014)
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Gudrun Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Comprehensive analysis of DNA methylation data with RnBeads
Yassen Assenov et al.
NATURE METHODS (2014)
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial
Benedikt Wiestler et al.
NEURO-ONCOLOGY (2014)
Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia
Christopher C. Oakes et al.
CANCER DISCOVERY (2014)
High-Definition Reconstruction of Clonal Composition in Cancer
Andrej Fischer et al.
CELL REPORTS (2014)
A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data
Andrew E. Teschendorff et al.
BIOINFORMATICS (2013)
Recurrent Pre-existing and Acquired DNA Copy Number Alterations, Including Focal TERT Gains, in Neuroblastoma Central Nervous System Metastases
David Cobrinik et al.
GENES CHROMOSOMES & CANCER (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Mark Sausen et al.
NATURE GENETICS (2013)
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
Marcel Martin et al.
NATURE GENETICS (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
H. Kocak et al.
CELL DEATH & DISEASE (2013)
PurityEst: estimating purity of human tumor samples using next-generation sequencing data
Xiaoping Su et al.
BIOINFORMATICS (2012)
Snakemake-a scalable bioinformatics workflow engine
Johannes Koester et al.
BIOINFORMATICS (2012)
Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways
Neerav Shukla et al.
CLINICAL CANCER RESEARCH (2012)
Mechanisms of CHD5 Inactivation in Neuroblastomas
Hiroshi Koyama et al.
CLINICAL CANCER RESEARCH (2012)
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer et al.
NATURE GENETICS (2012)
T-REX: a web server for inferring, validating and visualizing phylogenetic trees and networks
Boc Alix et al.
NUCLEIC ACIDS RESEARCH (2012)
High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma
Johannes H. Schulte et al.
CLINICAL CANCER RESEARCH (2011)
Treatment and Outcomes of Patients With Relapsed, High-Risk Neuroblastoma: Results of German Trials
Thorsten Simon et al.
PEDIATRIC BLOOD & CANCER (2011)
Cellular signaling of Dock family proteins in neural function
Yuki Miyamoto et al.
CELLULAR SIGNALLING (2010)
Neuroblastoma: Biology, Prognosis, and Treatment
Julie R. Park et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Tobias Otto et al.
CANCER CELL (2009)
Heterogeneity of the MYCN Oncogene in Neuroblastoma
Jessica Theissen et al.
CLINICAL CANCER RESEARCH (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Combined Immunodeficiency Associated with DOCK8 Mutations
Qian Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dedicator of cytokinesis 8 is disrupted in two patients with mental retardation and developmental disabilities
Bradley L. Griggs et al.
GENOMICS (2008)
CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas
Tomoyuki Fujita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Association of deletion 9p, 46,XY gonadal dysgenesis and autistic spectrum disorder
G. Vinci et al.
MOLECULAR HUMAN REPRODUCTION (2007)
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas
JH Schulte et al.
ONCOGENE (2005)
Share Paper
